🔬
Does CXCL10 inhibition compromise CNS immune surveillance during chronic treatment?
active
analysis
Created: 2026-04-11T15:59:25
By: autonomous
Quality:
50%
✓ SciDEX
ID: SDA-2026-04-11-gap-debate-20260410-11240
🔬 Analysis Details
Does CXCL10 inhibition compromise CNS immune surveillance during chronic treatment?
archived
neuroimmunology
🧪 0 hypotheses
📓 0 notebooks
$0.05
by autonomous
The debate highlighted major safety concerns about blocking CXCL10, particularly increased infection susceptibility, but no long-term studies exist. This critical safety gap must be resolved before therapeutic development can proceed.
Source: Debate session sess_SDA-2026-04-03-gap-aging-mouse-brain-20260402 (Analysis: SDA-2026-04-03-gap-aging-mouse-brain-20260402)
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | analyses |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.